Your session is about to expire
← Back to Search
HOLA Program for Preventing Cognitive Decline (HOLA-CD Trial)
N/A
Waitlist Available
Led By Daniel Jimenez, Ph.D.
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
are age 50+;
volunteer informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 16 weeks
Awards & highlights
HOLA-CD Trial Summary
This trial will test different ways of preventing cognitive decline in HIV+ Latino adults.
Who is the study for?
This trial is for Latino adults over 50 living with HIV who have their viral load under control. They must be able to walk and give informed consent, but can't join if they're undergoing cancer treatment, have significant hearing or vision loss, a history of serious brain trauma, any neurodegenerative diseases like Alzheimer's, or conditions that make exercise unsafe.Check my eligibility
What is being tested?
The study tests the 'Happy Older Latinos are Active (HOLA)' program to prevent memory loss and decline in mental function among older Latino adults with HIV. It aims to find effective strategies for maintaining cognitive health in this population.See study design
What are the potential side effects?
Since HOLA focuses on lifestyle changes and physical activity to improve cognitive function, side effects may include typical exercise-related issues such as muscle soreness or strain. However, participants with contraindications to physical activity are excluded from the trial.
HOLA-CD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 50 years old or older.
Select...
I have given my consent to participate.
Select...
I am HIV positive with a viral load under 200 copies/mL.
HOLA-CD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 16 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of participants completing the study
Secondary outcome measures
Changes in adiponectin
Changes in anxiety as measured by the GAD-7
Changes in biomarkers of cognition
+6 moreHOLA-CD Trial Design
1Treatment groups
Experimental Treatment
Group I: HOLA GroupExperimental Treatment1 Intervention
Participants in this group will receive a multicomponent intervention for 16 weeks.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
897 Previous Clinical Trials
409,230 Total Patients Enrolled
2 Trials studying Cognitive Decline
107 Patients Enrolled for Cognitive Decline
National Institute on Minority Health and Health Disparities (NIMHD)NIH
373 Previous Clinical Trials
1,214,426 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,655 Previous Clinical Trials
28,004,140 Total Patients Enrolled
31 Trials studying Cognitive Decline
22,774 Patients Enrolled for Cognitive Decline
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with a neurodegenerative disorder or dementia.I cannot walk 10 meters by myself.I do not have conditions affecting my thinking or senses, nor am I currently on cancer treatment, and I've never had a severe brain injury.I am 50 years old or older.I cannot safely do physical activities due to severe illness.I have given my consent to participate.I am HIV positive with a viral load under 200 copies/mL.You identify yourself as being of Latino ethnicity.
Research Study Groups:
This trial has the following groups:- Group 1: HOLA Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants can be enrolled in this research trial?
"Indeed, clinicaltrials.gov has the latest information regarding this medical study's recruitment status. It was posted on February 1st 2022 and revised lastly on November 14th 2022. 30 volunteers are needed from a single location to complete the trial."
Answered by AI
Are there any open slots still available in this clinical experiment?
"Per details on clinicaltrials.gov, this medical experiment is actively seeking volunteers; it was published on February 1st 2022 and the information has been updated most recently on November 14th 2022."
Answered by AI
Share this study with friends
Copy Link
Messenger